Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-27

Clinical Trial Update: Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating budesonide for patients with lung nodules at high risk of developing lung cancer; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-04-27